Abstract
Rosacea is one of the most common dermatoses of adults. A good understanding of the illness and its particularities is necessary for the differential diagnoses of the many clinical subtypes and in order to enable a stage- and phase-specific treatment approach. Topical treatments that are widely accepted are metronidazole and azelaic acid; agents under investigation that may have promising therapeutic effectiveness are permethrin and calcineurin inhibitors. Systemically, antibiotics, such as tetracyclines and macrolides, and in severe cases isotretinoin, can be used. Surgically, rhinophymas and teleangiectasias can be treated using lasers, dermabrasion or currettage. This review will give an overview regarding rosacea, a challenging condition with multiple therapeutic options.
Financial & competing interests disclosure
Percy Lehmann has received consultancies, fees and speech honoraria form Galderma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.